Neoadjuvant Avelumab Plus Axitinib Enabling Curative Resection of Renal Cell Carcinoma With Direct Liver Invasion: A Case Report
In select cases of organ-invasive non-metastatic RCC, short-term neoadjuvant therapy with avelumab plus axitinib may allow for complete resection and prolonged disease control.
Authors
- Gaku Hayashi (ORCID: https://orcid.org/0009-0000-0978-3230)
- Takashi Fujita (ORCID: https://orcid.org/0000-0001-9961-0535)
- Shunsuke Kamijo (ORCID: https://orcid.org/0009-0000-4832-7510)
- Fumihiro Ito (ORCID: https://orcid.org/0009-0007-7240-6113)
- Koki Kobayashi
Institutions
- Gifu Prefectural Tajimi Hospital (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/iju5.70124
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00